PROSPECTIVE RANDOMIZED TRIAL COMPARING PEGIFNALPHA 2A AND PEGIFN ALPHA 2B WITH RIBAVIRIN IN HCV-LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C

被引:0
|
作者
Aguilera, V. [1 ,2 ]
Prieto, M. [1 ,2 ]
Rubin, A. [1 ,2 ]
Risalde, B. [1 ,2 ]
Ortiz Canto, C. [2 ,3 ]
Berenguer, M. [1 ,2 ]
机构
[1] Hosp Univ La Fe, Serv Hepatogastroenterol, Valencia, Spain
[2] Inst Salud Carlos III, CIBEREHD, Valencia, Spain
[3] Hosp La Fe, Expt Immun Unit, E-46009 Valencia, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S184 / S184
页数:1
相关论文
共 50 条
  • [31] Interferon α 2B and ribavirin in severe recurrent cholestatic hepatitis C
    Ong, JP
    Younossi, ZM
    Gramlich, T
    Goodman, Z
    Mayes, J
    Sarbah, S
    Yen-Lieberman, B
    TRANSPLANTATION, 2001, 71 (10) : 1486 - 1488
  • [32] Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV- HIV Coinfected Liver Transplant Recipients
    Terrault, N.
    Reddy, K. R.
    Poordad, F.
    Curry, M.
    Schiano, T.
    Johl, J.
    Shaikh, O.
    Dove, L.
    Shetty, K.
    Millis, M.
    Schiff, E.
    Regenstein, F.
    Barnes, D.
    Barin, B.
    Peters, M.
    Roland, M.
    Stock, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (05) : 1129 - 1135
  • [33] Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
    Calmus, Yvon
    Duvoux, Christophe
    Pageaux, Georges
    Wolf, Philippe
    Rostaing, Lionel
    Vanlemmens, Claire
    Botta-Fridlund, Danielle
    Dharancy, Sebastien
    Gugenheim, Jean
    Durand, Francois
    Neau-Cransac, Martine
    Boillot, Olivier
    Chazouilleres, Olivier
    Samelson, Laurence
    Boudjema, Karim
    Samuel, Didier
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 564 - 571
  • [34] Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
    Rumi, Maria Grazia
    Aghemo, Alessio
    Prati, Gian Maria
    D'Ambrosio, Roberta
    Donato, Maria Francesca
    Soffredini, Roberta
    Del Ninno, Ersilio
    Russo, Antonio
    Colombo, Massimo
    GASTROENTEROLOGY, 2010, 138 (01) : 108 - 115
  • [35] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [36] A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus
    Ikeda, K
    Kumada, H
    Saitoh, S
    Suzuki, Y
    Kobayashi, M
    Tsubota, A
    Koida, I
    Fukuda, M
    Arase, Y
    Chayama, K
    Murashima, N
    Tango, T
    JOURNAL OF HEPATOLOGY, 1998, 28 (05) : 910 - 911
  • [37] Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis
    Prati, Gian Maria
    Aghemo, Alessio
    Rumi, Maria Grazia
    D'Ambrosio, Roberta
    De Nicola, Stella
    Donato, Maria Francesca
    Degasperi, Elisabetta
    Colombo, Massimo
    JOURNAL OF HEPATOLOGY, 2012, 56 (02) : 341 - 347
  • [38] Randomized Trial Comparing Pegylated Interferon α-2b Versus Pegylated Interferon α-2a, Both Plus Ribavirin, to Treat Chronic Hepatitis C in Human Immunodeficiency Virus Patients
    Laguno, Montserrat
    Cifuentes, Carmen
    Murillas, Javier
    Veloso, Sergio
    Larrousse, Maria
    Payeras, Antoni
    Bonet, Lucia
    Vidal, Francesc
    Milinkovic, Ana
    Bassa, Antoni
    Villalonga, Concha
    Perez, Inaki
    Tural, Cristina
    Martinez-Rebollar, Maria
    Calvo, Marta
    Luis Blanco, Jose
    Martinez, Estaban
    Sanchez-Tapias, Jose M.
    Gatell, Jose M.
    Mallolas, Jose
    HEPATOLOGY, 2009, 49 (01) : 22 - 31
  • [39] Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patients
    Mukherjee, S
    Lyden, E
    McCashland, TM
    Schafer, DF
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (02) : 198 - 203
  • [40] Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial
    Martin, P
    Busuttil, RW
    Goldstein, RM
    Crippin, JS
    Klintmalm, GB
    Fitzsimmons, WE
    Uleman, C
    LIVER TRANSPLANTATION, 2004, 10 (10) : 1258 - 1262